Cargando…
Correction to: Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy - a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study)
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053072/ https://www.ncbi.nlm.nih.gov/pubmed/32126964 http://dx.doi.org/10.1186/s12885-020-6678-x |
| _version_ | 1783502967121379328 |
|---|---|
| author | Schwarz, Lilian Vernerey, Dewi Bachet, Jean-Baptiste Tuech, Jean-Jacques Portales, Fabienne Michel, Pierre Cunha, Antonio Sa |
| author_facet | Schwarz, Lilian Vernerey, Dewi Bachet, Jean-Baptiste Tuech, Jean-Jacques Portales, Fabienne Michel, Pierre Cunha, Antonio Sa |
| author_sort | Schwarz, Lilian |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7053072 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-70530722020-03-10 Correction to: Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy - a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study) Schwarz, Lilian Vernerey, Dewi Bachet, Jean-Baptiste Tuech, Jean-Jacques Portales, Fabienne Michel, Pierre Cunha, Antonio Sa BMC Cancer Correction BioMed Central 2020-03-03 /pmc/articles/PMC7053072/ /pubmed/32126964 http://dx.doi.org/10.1186/s12885-020-6678-x Text en © The Author(s). 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Schwarz, Lilian Vernerey, Dewi Bachet, Jean-Baptiste Tuech, Jean-Jacques Portales, Fabienne Michel, Pierre Cunha, Antonio Sa Correction to: Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy - a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study) |
| title | Correction to: Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy - a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study) |
| title_full | Correction to: Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy - a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study) |
| title_fullStr | Correction to: Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy - a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study) |
| title_full_unstemmed | Correction to: Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy - a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study) |
| title_short | Correction to: Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy - a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study) |
| title_sort | correction to: resectable pancreatic adenocarcinoma neo-adjuvant folf(irin)ox-based chemotherapy - a multicenter, non-comparative, randomized, phase ii trial (panache01-prodige48 study) |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053072/ https://www.ncbi.nlm.nih.gov/pubmed/32126964 http://dx.doi.org/10.1186/s12885-020-6678-x |
| work_keys_str_mv | AT schwarzlilian correctiontoresectablepancreaticadenocarcinomaneoadjuvantfolfirinoxbasedchemotherapyamulticenternoncomparativerandomizedphaseiitrialpanache01prodige48study AT vernereydewi correctiontoresectablepancreaticadenocarcinomaneoadjuvantfolfirinoxbasedchemotherapyamulticenternoncomparativerandomizedphaseiitrialpanache01prodige48study AT bachetjeanbaptiste correctiontoresectablepancreaticadenocarcinomaneoadjuvantfolfirinoxbasedchemotherapyamulticenternoncomparativerandomizedphaseiitrialpanache01prodige48study AT tuechjeanjacques correctiontoresectablepancreaticadenocarcinomaneoadjuvantfolfirinoxbasedchemotherapyamulticenternoncomparativerandomizedphaseiitrialpanache01prodige48study AT portalesfabienne correctiontoresectablepancreaticadenocarcinomaneoadjuvantfolfirinoxbasedchemotherapyamulticenternoncomparativerandomizedphaseiitrialpanache01prodige48study AT michelpierre correctiontoresectablepancreaticadenocarcinomaneoadjuvantfolfirinoxbasedchemotherapyamulticenternoncomparativerandomizedphaseiitrialpanache01prodige48study AT cunhaantoniosa correctiontoresectablepancreaticadenocarcinomaneoadjuvantfolfirinoxbasedchemotherapyamulticenternoncomparativerandomizedphaseiitrialpanache01prodige48study |